{
    "id": "0375",
    "question": "A 22-year-old man with sickle cell disease is brought to the emergency room for acute onset facial asymmetry and severe pain. He was in school when his teacher noted a drooping of his left face. His temperature is 99.9\u00b0F (37.7\u00b0C), blood pressure is 122/89 mmHg, pulse is 110/min, respirations are 19/min, and oxygen saturation is 98% on room air. Physical exam is notable for facial asymmetry and 4/5 strength in the patient's upper and lower extremity. A CT scan of the head does not demonstrate an intracranial bleed. Which of the following is the most appropriate treatment for this patient?",
    "options": {
        "A": "Alteplase",
        "B": "Exchange transfusion",
        "C": "Heparin",
        "D": "Warfarin"
    },
    "answer": "B",
    "predict": "To approach this question, let's analyze the given information step by step: 1. **Patient Profile**: The patient is a 22-year-old man with sickle cell disease, which is a genetic disorder that affects hemoglobin production and can cause vaso-occlusive crises, among other complications. 2. **Symptoms**: The patient presents with acute onset facial asymmetry and severe pain, which suggests a possible stroke or cerebral vasculature event. The drooping of his left face could be indicative of a unilateral facial weakness, a common presentation of a stroke. 3. **Vital Signs**: The patient's vital signs are relatively stable, with a mild tachycardia (110/min) and mild tachypnea (19/min), but the temperature is normal. The oxygen saturation is within normal limits. 4. **Physical Exam**: The patient has facial asymmetry and decreased strength (4/5) in the upper and lower extremities, which supports the suspicion of a stroke or a significant neurological event. 5. **Diagnostic Test**: The CT scan of the head does not show an intracranial bleed, which reduces the likelihood of a hemorrhagic stroke but does not rule out an ischemic stroke or other causes of neurological deficits. Given these points, the patient's presentation is most consistent with a stroke, likely an ischemic stroke, given the absence of a hemorrhagic lesion on the CT scan. Now, let's evaluate the treatment options: - **A. Alteplase**: This is a thrombolytic agent used to dissolve blood clots in ischemic strokes. However, alteplase is typically used in patients with acute ischemic stroke within a certain time window (typically 3-4.5 hours from symptom onset), and the patient's symptoms have been ongoing for some time. - **B. Exchange Transfusion**: This is a procedure that involves replacing the patient's red blood cells with normal red blood cells to reduce the concentration of sickle hemoglobin. It is a recognized treatment for acute chest syndrome in sickle cell disease but is not directly indicated for acute ischemic stroke. - **C. Heparin**: Heparin is an anticoagulant that can be used to prevent further clotting in ischemic strokes. However, it is not a primary treatment for acute ischemic stroke. - **D. Warfarin**: Warfarin is an oral anticoagulant used to prevent recurrent strokes in patients with atrial fibrillation or other conditions that increase the risk of thromboembolism. It is not typically used for the treatment of acute ischemic stroke. Considering the patient's presentation of acute ischemic stroke and the need for immediate thrombolytic therapy to dissolve the clot, **A. Alteplase** is the most appropriate treatment, despite the slightly delayed presentation. However, the exact timing and appropriateness of alteplase administration should be confirmed with further evaluation and consultation with a neurologist. **\"step_by_step_thinking\": \"The patient's presentation of acute onset facial asymmetry and severe pain, in the context of sickle cell disease, is most consistent with an ischemic stroke. Alteplase is the most appropriate treatment for acute ischemic stroke, despite the slightly delayed presentation, as it can help dissolve the clot and restore blood flow to the affected area. However, further evaluation and consultation with a neurologist are necessary to confirm the diagnosis and timing of alteplase administration.\"** **\"answer_choice\": \"A\"**",
    "snippets": [],
    "scores": [],
    "execution_time": 20.021932125091553
}